Michael Gifford

Director of Commercialisation at NIAB

📍 London, England Metropolitan Area, United Kingdom🔄 Updated September 2026💼 2 investments📅 8 years investing🗓 Last invested Feb 2019
Operator-angel🌍 United Kingdom
2
Total investments
1
Early stage
1
Mid stage
0
Late stage
8y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board Observer
Feb 2019
Route Reports is a technology supplier that provides transport operators with cost-effective and cutting-edge solutions to improve the maintenance and operation of road and rail transport networks. We achieve this through the use of innovative hardware and software that is tailored for use in the transport industry, ultimately enhancing operators’ understanding of where infrastructure defects might become an obstacle to their operations - before they do. The end result is more punctual, more comfortable and more affordable journeys on roads and rail.
Investor
Apr 2018
Unlock the AI-Powered Conversational Data Intelligence for Healthcare Marketing Excellence Talking Medicines is transforming Healthcare Marketing by leveraging Advanced Data Science, Curated Large Language Models (LLMs), and Artificial Intelligence. Our mission is to unlock strategic intelligence within Healthcare Professional (HCPs) and Patient Conversational Data, providing actionable intelligence for Healthcare Marketing Agencies. Advanced-Data Science: Utilize cutting-edge data science techniques to analyze vast amounts of HCP and Patient Conversational Data, uncovering unseen intelligence that drive strategic decision-making. Curated Large Language Models: Implement expertly curated LLMs to accurately interpret and understand the difference in healthcare conversations for actionable Intelligence. Artificial Intelligence: Harness the power of AI to process and analyze Conversational Data, transforming raw information into strategic intelligence that enhances marketing efforts and ROI. Natural Language Interface: Delivers intelligence to customers through an intuitive natural language interface, making it easy to access and understand complex data. Just ask Drug-GPT what you want to know! At Talking Medicines, we are committed to revolutionizing Healthcare Marketing by providing our customers with the tools and intelligence they need to succeed in an increasingly complex and data-driven world.   Learn more: https://www.talkingmedicines.com
Experience · 8 entries
All (8)
Investments (2)
Founder (2)
Board (1)
2024
Honorary Associate Professor - School of Biosciences
Jun 2024
The University of Nottingham is a pioneering university that transforms the lives of our 45,000 students at our campuses in the UK, China and Malaysia.
2019
Investor & Board Observer
Feb 2019
Route Reports is a technology supplier that provides transport operators with cost-effective and cutting-edge solutions to improve the maintenance and operation of road and rail transport networks. We achieve this through the use of innovative hardware and software that is tailored for use in the transport industry, ultimately enhancing operators’ understanding of where infrastructure defects might become an obstacle to their operations - before they do. The end result is more punctual, more comfortable and more affordable journeys on roads and rail.
2018
Investor
Apr 2018
Unlock the AI-Powered Conversational Data Intelligence for Healthcare Marketing Excellence Talking Medicines is transforming Healthcare Marketing by leveraging Advanced Data Science, Curated Large Language Models (LLMs), and Artificial Intelligence. Our mission is to unlock strategic intelligence within Healthcare Professional (HCPs) and Patient Conversational Data, providing actionable intelligence for Healthcare Marketing Agencies. Advanced-Data Science: Utilize cutting-edge data science techniques to analyze vast amounts of HCP and Patient Conversational Data, uncovering unseen intelligence that drive strategic decision-making. Curated Large Language Models: Implement expertly curated LLMs to accurately interpret and understand the difference in healthcare conversations for actionable Intelligence. Artificial Intelligence: Harness the power of AI to process and analyze Conversational Data, transforming raw information into strategic intelligence that enhances marketing efforts and ROI. Natural Language Interface: Delivers intelligence to customers through an intuitive natural language interface, making it easy to access and understand complex data. Just ask Drug-GPT what you want to know! At Talking Medicines, we are committed to revolutionizing Healthcare Marketing by providing our customers with the tools and intelligence they need to succeed in an increasingly complex and data-driven world.   Learn more: https://www.talkingmedicines.com
2016
COO & Co-Founder
Oct 2016
The IAND digital platform helps companies to optimise supplier collaboration on projects and frameworks to deliver targets on performance, social value and innovation.
2014
Managing Director
Jan 2014
PANGAEA AGROCHEMICALS LIMITED is a management consulting company based out of ST JOHN’S INNOVATION CENTRE COWLEY ROAD, CAMBRIDGE, England, United Kingdom.
Show all 8 entries ↓